St. Jude Medical
St. Jude Medical was founded in 1976 in St. Paul, Minnesota, USA, as a pioneering manufacturer of bi-leaflet implantable mechanical heart valves which soon became the “gold standard” for mechanical heart valves.Since its first major acquisition of Pacesetter™ in 1994, St. Jude Medical has continued to grow into a global leader in cardiac and neurological device technology.
St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro).
St. Jude Medical has a global network of more than 20 principal operations and manufacturing facilities providing products and expertise to customers in more than 100 countries.
Dirk Tryusho - head of clinical support of St.Jude Medical products for endovascular interventions in Eastern Europe (Belgium), in February 2014 introduced a new technology for study of the cardiovascular system, which is called the FFR (regional flow reserve) at the department of angiography of Erebouni MC. He has purpose to train the specialists of the center in the new methodology with its soon implementation to everyday practice.